The healthcare industry has crossed a threshold from experimentation to implementation. NVIDIA's State of AI in Healthcare survey, polling over 600 respondents, reveals 70% of organizations now actively deploy AI, up from 63% one year earlier.

Eighty-five percent of executives report AI increases revenue, while 80% cite cost reductions. More than half report at least 2x ROI on AI deployments. Eighty-five percent plan to increase AI spending, with 46% expecting budget increases exceeding 10%.

"Over the next 12-18 months, the most visible and scalable impact will come from logistic administrative streamlining."

— John Nosta

Over the next 12-18 months, the most visible and scalable impact will come from logistic administrative streamlining, noted healthcare think tank president John Nosta.

Medical imaging leads use cases: 61% of medical technology respondents use AI for imaging, with 57% seeing clear ROI. In pharma, 46% identify AI drug discovery as their top ROI use case. Generative AI and LLMs are the top-ranked workload (69%, up from 54% prior year). Forty-seven percent are exploring agentic AI.

70% Healthcare organizations actively deploying AI (up from 63% in 2024)
85% Of executives reporting AI increases revenue; 80% cite cost reductions
57% Of medical technology firms seeing ROI from AI-powered medical imaging
46% Of pharma/biotech respondents citing AI drug discovery as top ROI use case

Open-source is important: 82% view open-source models as moderately to extremely important. Digital healthcare organizations lead adoption at 78%, followed by medical technology at 74%.

The survey signals healthcare has transformed AI from experimental luxury to operational necessity.